Adrienne Lovink leads Trinity’s Real-World-Evidence team. She has almost 20 years-experience working with medical device, pharmaceutical, and health technology companies on issues related to commercialization strategy, product and portfolio planning, and market access. She and her team have helped shape the evolution in the use of RWD based on the growing availability of data and its potential to be leveraged across the product development lifecycle. Prior to joining Trinity, Adrienne spent 15 years at Decision Resources Group, part of Clarivate. Her last post at DRG was as the Global Head of Real-World-Data and Applied Analytics. She also spent many years as a Partner in DRG Global Consulting Services
Analysis in Context: The Only Way to be “Right”
Given the increasing availability of both broad and deep healthcare data, life sciences companies are more reliant on real-world-evidence (RWE) to support decision-making. Most practitioners are unprepared for the investment required. Unlocking the power of RWD requires a sophisticated understanding of the data, the analytics, and the disease - Analysis in Context.